Research progress on the relationship between erythropoietin and retinopathy of prematurity by Heng Zhang, Xiao-Rong Li, Long-Li Zhang

Subjects: “…erythropoietin…”
Get full text

Effects of Angiotensin II on Erythropoietin Production in the Kidney and Liver by Yukiko Yasuoka, Yuichiro Izumi, Takashi Fukuyama, Hideki Inoue, Tomomi Oshima, Taiga Yamazaki, Takayuki Uematsu, Noritada Kobayashi, Yoshitaka Shimada, Yasushi Nagaba, Masashi Mukoyama, Yuichi Sato, Jeff M Sands, Katsumasa Kawahara, Hiroshi Nonoguchi

Subjects: “…erythropoietin…”
Get full text

Neuroprotective effects of erythropoietin on rat retinas subjected to oligemia by Litia Alves de Carvalho, Renata Fleming, Moysés Sant’Anna, Roberta Guimarães, Adalmir Morterá Dantas, Eduardo Morizot-Leite, Leny A. Cavalcante, Silvana Allodi

“…OBJECTIVES: Erythropoietin may have neuroprotective potential after ischemia of the central nervous system. …”
Get full text

Effect of Erythropoietin on the Expression of Murine Transferrin Receptor 2 by Betty Berezovsky, Martin Báječný, Jana Frýdlová, Iuliia Gurieva, Daniel Wayne Rogalsky, Petr Přikryl, Vít Pospíšil, Emanuel Nečas, Martin Vokurka, Jan Krijt

“…Erythropoietin (EPO) downregulates hepcidin expression to increase the availability of iron; the downregulation of hepcidin is mediated by erythroferrone (ERFE) secreted by erythroblasts. …”
Get full text

New alternatives for erythropoietin therapy in chronic renal failure by Stoian Irina, Manolescu Bogdan, Atanasiu Valeriu, Lupescu Olivera

Subjects: “…erythropoietin…”
Get full text

Complex regional pain syndrome associated with erythropoietin therapy by Ana Coloma, Nuria Sánchez, David Fuster, Cristina Ruiz, Marc Xipell, John Orozco, Andrés Tapias, José V. Torregrosa

Get full text

Erythropoietin level in normal and abnormal human seminal fluid by D. Yu. Sosnin, K. R. Galkovich, A. V. Krivtsov1

Subjects: “…erythropoietin…”
Get full text

Erythropoietin enhances hippocampal long-term potentiation and memory by El-Kordi Ahmed, Radyushkin Konstantin, Sperling Swetlana, Hannke Kathrin, Hassouna Imam, Müller Michael, Zhang Mingyue, Theis Fabian, Gertler Christoph, Medrihan Lucian, Stradomska Alicja, Sargin Derya, Adamcio Bartosz, Schulze Lizzy, Ronnenberg Anja, Wolf Fred, Brose Nils, Rhee Jeong-Seop, Zhang Weiqi, Ehrenreich Hannelore

“…<p>Abstract</p> <p>Background</p> <p>Erythropoietin (EPO) improves cognition of human subjects in the clinical setting by as yet unknown mechanisms. …”
Get full text

Erythropoietin – a potential tool in the treatment of depressive disorders? by G. Simões, S. Jesus, R. Silva

Subjects: Get full text

Biological evaluation of recombinant human erythropoietin in pharmaceutical products by A.S. Ramos, C.A. Schmidt, S.S. Andrade, M. Fronza, B. Rafferty, S.L. Dalmora

Subjects: “…Recombinant human erythropoietin…”
Get full text

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders by Khalil Ghasemi Falavarjani, Mehdi Modarres

Get full text

Stability of erythropoietin repackaging in polypropylene syringes for clinical use by Angela Marsili, Giorgia Puorro, Chiara Pane, Anna de Rosa, Giovanni Defazio, Carlo Casali, Antonio Cittadini, Giuseppe de Michele, Brunello Ettore Florio, Alessandro Filla, Francesco Saccà

Subjects: “…Erythropoietin…”
Get full text

Effects of Erythropoietin on Cardiac Remodeling After Myocardial Infarction by Nishiya Daisuke, Omura Takashi, Shimada Kenei, Matsumoto Ryo, Kusuyama Takanori, Enomoto Soichiro, Iwao Hiroshi, Takeuchi Kazuhide, Yoshikawa Junichi, Yoshiyama Minoru

“…Abstract.: Erythropoietin (EPO) has been suggested to have a cardioprotective effect against ischemia. …”
Get full text

Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients by V. A. Titova, Yu. M. Kreynina, A. N. Shipilova, L. N. Shevchenko, V. Yu. Petrovsky, I. V. Ose, T. F. Skobeleva, A. V. Akimov, A. L. Badmayev

“…The clinical application of recombinant human erythropoietin preparations has become an important treat- ment step that permits multiple hemotransfusions to be avoided. …”
Get full text

Recognition and characterization of Erythropoietin binding-proteins in the brain of mice by Reza Kowsari, Rezvan Yazdian-Robati, Bibi Marjan Razavi, Atena Pourtaji, Maryam Ghorbani, Hediye Moghadam-Omranipour, Hossein Hosseinzadeh, Parisa Lari, Khalil Abnous

Subjects: Get full text

Cost-effectiveness of continuous erythropoietin receptor activator in anemia by Schmid H

“…Holger Schmid1,21Clinic and Policlinic IV, Section of Nephrology, Munich University Hospital, Campus Innenstadt, Munich, Germany; 2KfH Nierenzentrum Muenchen Laim, Munich, GermanyBackground: Erythropoiesis-stimulating agents (ESAs) are the mainstay of anemia therapy. Continuous erythropoietin receptor activator (CERA) is a highly effective, long-acting ESA developed for once-monthly dosing. …”
Get full text

Insights from the use of erythropoietin in experimental Chagas disease by Ana Carolina de Castro Nobre, Carlos Fernando Pimentel, George Magno Sousa do Rêgo, Giane Regina Paludo, Glaucia Bueno Pereira Neto, Márcio Botelho de Castro, Nadjar Nitz, Mariana Hecht, Bruno Dallago, Luciana Hagström

Subjects: Get full text

Erythropoietin re-wires cognition-associated transcriptional networks by Manvendra Singh, Ying Zhao, Vinicius Daguano Gastaldi, Sonja M. Wojcik, Yasmina Curto, Riki Kawaguchi, Ricardo M. Merino, Laura Fernandez Garcia-Agudo, Holger Taschenberger, Nils Brose, Daniel Geschwind, Klaus-Armin Nave, Hannelore Ehrenreich

“…Abstract Recombinant human erythropoietin (rhEPO) has potent procognitive effects, likely hematopoiesis-independent, but underlying mechanisms and physiological role of brain-expressed EPO remained obscure. …”
Get full text

Erythropoietin; bright future and new hopes for an old drug by Mehri Kadkhodaee

Subjects: “…erythropoietin…”
Get full text

4097 Transcriptome and molecular analysis of erythropoietin-induced hypertension by Nitin Kumar, Isabelle birt, Kristina L. Hunker, Santhi K. Ganesh

“…OBJECTIVES/GOALS: High blood-pressure (BP) is a common adverse effect of erythropoietin (EPO) therapy among patients with chronic kidney disease on hemodialysis, and even among otherwise healthy individuals who receive EPO. …”
Get full text